![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 27, 24659-24666, July 5, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,From the Division of Molecular Medicine, City of Hope National Medical Center and Beckman Research Institute, Duarte, California 91010
Received for publication, December 14, 2001, and in revised form, April 17, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Flap endonuclease-1 (FEN-1) is a critical enzyme
for DNA replication and repair. Intensive studies have been carried out
on its structure-specific nuclease activities and biological functions in yeast cells. However, its specific interactions with DNA substrates as an initial step of catalysis are not defined. An understanding of
the ability of FEN-1 to recognize and bind a flap DNA substrate is
critical for the elucidation of its molecular mechanism and for the
explanation of possible pathological consequences resulting from its
failure to bind DNA. Using human FEN-1 in this study, we identified two
positively charged amino acid residues, Arg-47 and Arg-70 in
human FEN-1, as candidates responsible for substrate binding. Mutation
of the Arg-70 significantly reduced flap endonuclease activity and
eliminated exonuclease activity. Mutation or protonation of Arg-47
shifted cleavage sites with flap substrate and significantly reduced
the exonuclease activity. We revealed that these alterations are due to
the defects in DNA-protein interactions. Although the effect of the
single Arg-47 mutation on binding activities is not as severe as R70A,
its double mutation with Asp-181 had a synergistic effect. Furthermore
the possible interaction sites of these positively charged residues
with DNA substrates were discussed based on FEN-1 cleavage patterns
using different substrates. Finally data were provided to indicate that
the observed negative effects of a high concentration of
Mg2+ on enzymatic activity are probably due to the
competition between the arginine residues and metal ions with DNA
substrate since mutants were found to be less tolerant.
Flap endonuclease-1
(FEN-1)1 proteins possess a
flap endonuclease activity as well as a 5' to 3' exonuclease activity
(1-5). These nuclease activities allow FEN-1 proteins to remove the
RNA primers during lagging-strand DNA synthesis and damaged DNA
fragments in various DNA repair pathways (6-11). Besides its nuclease
activities, it interacts with various proteins involved in DNA
metabolic pathways including the Werner syndrome protein (12) and
proliferating cell nuclear antigen (PCNA) (13, 14). FEN-1 localizes
into the nucleus in S phase during DNA synthesis as well as in response to DNA damage (15). In yeast, loss of FEN-1 functions was determined to
cause severely impaired phenotypes such as conditional lethality, dramatic increase of cellular sensitivity to alkylating agents, e.g. methyl methanesulfonate, and significant
increase in the mutation rate. Interestingly a majority of mutations in
the yFEN-1 mutant strains are large sequence duplications (10).
Duplication mutations in humans have been associated with disorders
such as recessive retinitis pigmentosa, lethal junctional epidermolysis bullosa, familial hypertrophic cardiomyopathy, and cancer. FEN-1 is
also a key enzyme for preventing expansion and contraction of bi- or
trinucleotide repeats (16-19). More recently we have demonstrated that
FEN-1 nuclease plays an important role in limiting short sequence
recombination for yeast genome stability (20). All of these
observations illustrate its critical roles in genome integrity.
As an essential gene for DNA replication, FEN-1 defects resulting in a
complete loss of function are unlikely to exist in the human population
(21, 22). A comprehensive structural and functional analysis of single
amino acid residue mutations will assist in the formulation of models
for biological and pathological roles of this enzyme. Initial domain
analysis based on protein sequence comparison and biochemical assays
displayed two major conserved motifs, N (N-terminal) and I
(intermediate) motifs, which are essential for the nuclease activities
of FEN-1 proteins (4, 23). A third motif at the C-terminal end is
involved in the interaction of FEN-1 proteins with PCNA (23-25).
Although we have recently demonstrated that stimulation of eukaryotic
FEN-1 activities by PCNA is independent of its in vitro
interaction via a consensus PCNA binding region (25), the interaction
may be crucial for PCNA to recruit FEN-1 onto Okazaki fragment
processing and DNA damage sites (24, 26-28). An additional C-terminal
motif exists in eukaryotic cells that is responsible for the
localization of FEN-1 protein into the nucleus (15). In recent years,
we have performed site-directed mutagenesis on human FEN-1 nuclease coupled with biochemical and yeast genetic analysis. A number of amino
acid residues, which are critical for biochemical and biological
functions, have been revealed through this ongoing endeavor. The
structural and functional relationship of these identified amino
acid residues is summarized in Table
I.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Critical amino acid residues identified in human FEN-1 via
site-directed mutagenesis and biochemical analysis
Although relatively abundant information on the structural and
functional relationship of some FEN-1 proteins is available, identification of structural elements for DNA substrate binding has
been a difficult task without a three-dimensional structure of the
protein-DNA complex. To identify amino acid residues directly involved
in substrate binding, we constructed a three-dimensional molecular
model for human FEN-1 based on the available homologous crystal
structures (29-33). We have identified 10 amino acid residues including Arg-29, Arg-47, Arg-70, Arg-73, Lys-80, Lys-93, Lys-99, Arg-100, Arg-103, and Arg-104 as candidate residues that directly interact with DNA substrates. These residues are conserved in eukaryotes and are located on the surface of the molecule. We have
performed site-directed mutagenesis on these residues. Indeed individual mutations of many of these residues affect biochemical activities. The first five residues are located in the N-terminal
-helix and
-sheet region near the active center of the enzyme, while the other five residues are exclusively in the loop region, which
has been proposed to interact with the single-stranded flap of the DNA
substrate (32, 33). In this report, we focused on the first five
residues (Arg-29, Arg-47, Arg-70, Arg-73, and Lys-80) and determined
that Arg-47 and Arg-70 are important for the interaction with the DNA
substrates. Arg-70 might interact with the upstream double-stranded
region of the DNA substrates, and Arg-47, possibly interacting with the
upstream template region of DNA substrate, was revealed to play a role
in determining cleavage sites via mutational analysis, biochemical
assays, protonation, and competition experiments.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Site-directed Mutagenesis, Overexpression, and Purification of FEN-1-- All mutant proteins created for this study were prepared using the QuikChangeTM site-directed mutagenesis kit from Stratagene (La Jolla, CA). Mutagenic primers were synthesized at the City of Hope DNA/RNA/peptide synthesis core facility. Mutations and corresponding oligo sequences for primers are listed in Table II for clarity. Site-directed mutagenesis, overexpression, and purification of the wild type and mutant FEN-1 and Rad27 proteins were carried out based on our previously published procedures (15, 34-36). Mutagenesis reactions contain 50 ng of template pET28-derived plasmids harboring the wild type human FEN-1 sequence (37) so that the isolated plasmids containing a mutation can be directly expressed in Escherichia coli.
|
DNA Substrate Preparation and FEN-1 Nuclease Activity
Assays--
The oligos used to formulate nuclease substrates are also
listed in Table II. Protocols for DNA substrate preparation and nuclease activity assays were based on a previous publication (34).
Briefly, Flap-G1 (labeled oligo of the flap substrate), Flap-ND
(labeled oligo for single flap substrate and double flap substrate), or
Exo-3PT (labeled oligo of exonuclease substrate) were individually
phosphorylated at the 5' end. This was done by incubating 40 pmol of
the oligo with 10 µCi of [
-32P]ATP and 1 µl (10 units/µl) of polynucleotide kinase at 37 °C for 60 min.
Polynucleotide kinase was then inactivated by heating at 72 °C for
10 min. 80 pmol each of the Temp-3B and Prim-1G oligos were added to
the labeled oligos, respectively. The samples were incubated at
70 °C for 5 min followed by slow cooling to 25 °C, allowing the
oligos to slowly anneal and form the flap endonuclease and exonuclease
substrates as shown in Fig. 2, B and C.
Substrates were precipitated at
20 °C overnight after adding 20 µl of 3 M NaOAc and 1 ml of 100% ethanol. Substrates
were collected by centrifugation, washed once with 70% ethanol, and
resuspended in sterile water.
Reactions were carried out with the amount of hFEN-1 protein as indicated and 500 fmol of flap or exonuclease substrate with reaction buffer containing 50 mM Tris (pH 8.0) 10 mM MgCl2, and 100 µg/ml bovine serum albumin. Each reaction was then brought to a total volume of 13 µl with water. All reactions were incubated at 30 °C for 15 min and terminated by adding an equal volume of stop solution (95% formamide, 20 mM EDTA, 0.05% bromphenol blue, and 0.05% xylene cyanol). An aliquot of each reaction was then run on a 12% denaturing polyacrylamide gel at 1900 V for 1 h. The gel was dried at 70 °C for 50 min and then visualized by autoradiography.
Kinetic Analysis--
FEN-1 cleavage kinetics were performed
using various concentrations of DNA substrates (31.25-500
nM) and constant amounts of FEN-1 (92 nM)
following the procedures described in Hosfield et al. (35).
Briefly, reactions were initiated by combining standard reaction
buffer, substrate, and enzyme in that order. Samples were mixed
and incubated for 10 min. The products and substrate were separated by
denaturing gel electrophoresis. The initial velocity was calculated by
measuring products and substrate intensity on the gel by using the IP
Lab Gel program and by using the equation
= {I1/(I0
+0.5I1)t} × [substrate],
where t = time in seconds, I1 = product intensity, and I0 = final substrate
concentration. The substrate concentration was expressed in
nM. Vmax and Km values were calculated by directly fitting the data to the
Michaelis-Menten equation, and kcat and
kcat/Km were then derived.
Nuclease Activity Competition Assay-- The experiment was based on a constant amount of wild type protein with various concentrations of each mutant protein. Three mutants were used for this analysis, including D181A, R47A/D181A, and R70A/D181A. A plasmid overexpressing the D181A mutant gene (D181A/pET) was constructed previously (38). Based on this plasmid, two other mutants, R47A/D181A and R70A/D181A, were constructed, overexpressed, and purified. The competition assay was conducted with standard reaction buffer and 32P-labeled substrates as described above. The amount of wild type hFEN-1 and mutant proteins are as specified in the Fig. 3 legend. After a 15-min incubation at 30 °C, the reaction was stopped with stop solution. The products and substrate were separated by 10% denaturing PAGE to assess the substrate binding capacity of the mutants.
Direct Enzyme/Substrate Binding Analysis--
This assay was
conducted using immobilized substrates on beads and based on a method
modified from Gomes and Burgers (39). Briefly, 1 nM Temp-1G
with biotin at the 5' end (5'-Biotin-GGACTCTGCCTCAAGACGGTAGTCAACGTG-3') (Integrated DNA Technologies, Inc., Coralville, IA) was annealed to 1.5 nM Prim-3B (5'-CACGTTGACTACCGTC-3') and 1.5 nM Flap-G1 (5'-GATGTCAAGCAGTCCTAACTTTGAGGCAGAGTCC-3') for
flap substrate or Exo-3PT (5'-TTGAGGCAGAGTCC-3') for exonuclease
substrate. The annealed flap endo- or exonuclease substrate was
immobilized to the NeutrAvidinTM beads in buffer A (10 mM Tris-HCl, pH 7.5, 1 mM EDTA, and 1 M NaCl) by incubation for 2-3 h at room temperature. The
unbound substrate was washed off with buffer A. The bead-bound
substrate was resuspended in buffer C (30 mM HEPES-NaOH, pH
7.5, 125 mM NaCl, 0.2 mg/ml bovine serum albumin, and 1 mM dithiothreitol). The binding assay was performed on ice
for 20 min in a 16-µl reaction volume in buffer C with addition of 8 µl of substrate-bound beads and the amount of protein as indicated in
the Fig. 4 legend. The beads were then washed twice with prechilled
buffer B (30 mM HEPES-NaOH, pH 7.5, 5% glycerol, 0.1 mg/ml
bovine serum albumin, 1 mM dithiothreitol, 0.01% Nonidet
P-40, 0.1 mM EDTA, and 125 mM NaCl). 12 µl of
2× protein sample loading buffer was then added. The reaction mixture was boiled for 5 min to release the FEN-1 protein from the beads. After
a 2-min centrifugation at 14,000 rpm, the supernatant was loaded onto
the 10% SDS-polyacrylamide gel. The proteins were blotted onto a
nitrocellulose membrane (Schleicher & Schuell) using a Trans-Blot SD
semidry electrophoretic transfer cell from Bio-Rad. The blot was probed
with polyclonal antibodies raised in rabbits against hFEN-1 (36). A
specific FEN-1 protein was detected using the Pierce SuperSignal West
Pico chemiluminescence kit and a protocol recommended by the manufacturer.
| |
RESULTS |
|---|
|
|
|---|
Mutations of Arg-47 or Arg-70 Affected hFEN-1 Nuclease
Activities--
Since a three-dimensional crystal structure of human
FEN-1 has not been solved, we constructed a molecular model of hFEN-1 using the archaebacterial structures. Based on that model of hFEN-1 (Fig. 1), five residues including Arg-29,
Arg-47, Arg-70, Arg-73, and Arg-80 were visualized on the surface of
the molecule near the catalytic center. To experimentally test the
roles of these amino acid residues in substrate binding and nuclease
activity, we created the following non-conservative amino acid
substitution mutants: R29A, R47A, R70A, R73A, R80A, R47A/R70A, and
R70A/R73A. The mutant proteins were overexpressed and purified to
photographic homogeneity as shown in Fig.
2A. These proteins were then
assayed for their FEN-1 activities. Fig. 2, B and
C, shows that only R47A or R70A among the five single
mutants had a significant effect on FEN-1 enzyme activities.
Subsequently R47A, R70A, R73A (as a control since it is so close to
Arg-70), R47A/R70A, and R70A/R73A were included for further
investigations. The R47A and R70A mutants had a more severe impact on
exonuclease rather than on flap endonuclease activity. R70A
significantly reduced exonuclease activity while retaining most of its
flap endonuclease activity (Table III).
In contrast, the R47A mutation maintained both activities but shifted the endonuclease cleavage site from nucleotide position 19 (Pos19) to
21 (Pos21) on the flap strand and the exonuclease cleavage site from
Pos1, Pos2, and Pos3 to Pos2 and Pos3. Double mutants R47A/R70A and
R70A/R73A failed to show a synergistic effect on nuclease activities.
In fact, the combined mutational effect of R47A and R70A as well as
R70A and R73A was additive (Fig. 2, B and C).
|
|
|
R47A and R70A Have Km Values Greater than Wild Type hFEN-1 Protein-- To further explore the roles of Arg-47 and Arg-70 in substrate DNA binding, we performed kinetic analysis of the wild type and mutant hFEN-1 enzymes. Conventional steady-state kinetic analyses were carried out using various concentrations of radioactively labeled substrates, a constant amount of enzyme, and gel electrophoresis. We then measured cleavage activity with both the flap endo- and exonuclease DNA substrates. The results were analyzed using Michaelis-Menten kinetics to derive Km, kcat, and kcat/Km values as listed in Table III. While the kcat values for flap endonuclease activity were largely not affected, Km values for the R70A, R47A/R70A, and R70A/R73A mutants were doubled. The second order rate constants (kcat/Km) for these three mutants were significantly reduced (3-fold) with the endonuclease activity, suggesting that residue Arg-70 is critical for DNA substrate binding. Interestingly the R47A/R70A double mutant again revealed an additive effect on kinetic parameters. The effects of these mutations to the exonuclease activity were so severe that their kinetic parameters were not measurable any more. The Km of the R47A exonuclease activity was slightly increased, while the kcat and second order rate constant were both decreased.
Competition Assays Indicated That R47A and R70A Significantly
Reduced Substrate Binding Ability--
Since R47A and R70A of hFEN-1
retained partial flap endonuclease activity, they could not be directly
used for the competition assays. However, our previous studies
indicated that the D181A hFEN-1 mutant had a wild type or even enhanced
binding capability but lost cleavage activity, and it could
compete for substrates with the wild type enzyme and suppress
wild type enzyme activity (38). The competition assay utilized in our
current study has been established based on these observations. Knowing
the biochemical characteristics of the D181A mutant, we created two
double mutants D181A/R47A and D181A/R70A to confirm the roles of
the Arg-47 and Arg-70 residues in DNA binding. Null nuclease activities
of these mutants were verified before they were used in competition
assays. Circular dichroism spectra of the wild type, single mutants,
and double mutants were taken and compared to confirm that no
significant structural alterations took place due to these mutations
(data not shown). Then if Arg-47 and Arg-70 are involved in DNA
binding, the double mutant proteins, R47A/D181A and R70A/D181A, should demonstrate reduced DNA substrate binding ability in contrast to the
D181A mutant. The competition assays were performed based on a constant
amount of wild type hFEN-1 protein and increasing amounts of mutant
proteins (D181A, R47A/D181A, or R70A/D181A). The result indicates that
the double mutants did in fact have a significantly reduced ability to
suppress the enzyme activity of the wild type hFEN-1 protein (Fig.
3, A and B).
R47A/D181A had even more severe effects on substrate binding.
|
Direct DNA-Protein Binding Assays Confirmed the Critical Role of
Arg-47 and Arg-70 for DNA Binding of hFEN-1--
To further examine
the roles of Arg-47 and Arg-70 in substrate binding, we performed
DNA-protein binding assays. This assay was conducted using biotinylated
DNA substrates immobilized onto avidin-coated beads. After FEN-1
proteins were loaded onto the beads with the DNA substrates, the
remaining unbound proteins were removed by extensively washing the
beads. Bound protein was then dissociated by boiling and subsequently
detected by Western blotting using anti-hFEN-1 antibody. The result of
this experiment is shown in Fig. 4,
A and B, with the flap DNA and exonuclease substrates. It is clear that R47A and R70A mutations produced significantly lower binding affinity to both of the substrates.
|
Changes of Cleavage Intensities and Patterns of FEN-1 Proteins with
Different DNA Substrates--
The above data allow us to propose that
the two amino acids, Arg-47 and Arg-70, are involved in DNA binding of
FEN-1 protein. One further question is which parts of the DNA substrate
interact with these two amino acids. We designed an experiment using
five different substrates. Some of the substrates lack a part of the configuration of the normal double flap substrate. The names and different structural elements of the substrates are indicated in Fig.
5. Analysis of various responses
of the wild type protein and R47A and R70A mutants to the different
substrates was expected to delineate the specific site of the normal
substrate that interacts with these two residues. Fig. 5A
shows the cleavage results of three FEN-1 proteins based on
normal flap, pseudo Y, and 5' overhanging substrates. The result with
the normal flap substrate was consistent with those described for Fig.
1B. That is, R70A mutant had a reduction of enzyme cleavage
capability but had no change of cleavage sites in comparison to the
wild type; however, mutation R47A changed both cleavage efficiency and
sites (a shift from Pos19 to Pos21 and larger products). With
pseudo Y substrate missing the upstream primer, the enzyme
activities of the wild type and the R47A and R70A mutants were reduced,
particularly at the Pos21 cleavage site. With a 5' overhanging
substrate, the enzyme activities of the three FEN-1 proteins were all
further reduced, and the cleavage products were shifted up to 21, 22, and 23 nt without any 19-nt product. The wild type had new cutting
sites on the single-stranded flap. R70A seemed to have an equivalent or
greater enzyme activity compared with the wild type when the
products of the wild type enzyme were totaled, whereas R47A had a
weaker enzyme activity than that of R70A or wild type FEN-1.
|
In addition to the above findings, we further tested whether Arg-47 and Arg-70 could be responsible for the interaction with the 3' end-overlapping nucleotide of the upstream primer in the double flap substrate. It has recently been reported that FEN-1 enzyme activity can be significantly stimulated by the addition of an extra nucleotide (cytosine) at the 3' end of the upstream primer of the normal flap substrate (40). We would expect to see the loss or significant reduction of the activity stimulation in the two mutants, R70A and R47A, if the two amino acids are important for the interaction with the 3' overlapping nucleotide of the upstream primer of the double flap substrate. Obviously this study gave an opposite result (Fig. 5B). Based on these data, we propose that Arg-47 and Arg-70 residues interact with the upstream duplex of the flap substrate.
Protonation of Arg-47 or Arg-70 Resulted in a Single Cleavage Site
at Pos21 Resembling R47A Mutation--
The endonucleolytic activity of
hFEN-1 produces two major products. The cleavage sites of these two
products are at Pos21 and Pos19, counting from the 5' end of the flap
DNA strand. When the positively charged amino acid residue Arg-47 was
replaced by a neutral alanine, the cleavage site preferentially shifts from Pos19 to Pos21. We show here that the cleavage sites of hFEN-1 proteins were altered with the change of pH value for both the wild
type and mutants except R47A (Fig. 6).
Interestingly, under basic conditions beyond pH 7.2, the 19-nt product
appeared more than the 21-nt product, whereas the 21-nt product
accumulated when pH was more acidic. This phenomenon indicates that
protonation of Arg-47 may shift the area or position of
substrate-protein interactions, resulting in a single cleavage site as
seen in the R47A mutant (Fig. 6A). Similarly the cleavage
sites in the exonuclease substrate shifted to Pos2 and Pos3 when the
proteins were protonated (Fig. 6B).
|
Mutations of Arg-47 and Arg-70 Produced an Enzyme That Is Less
Tolerant of Mg2+ Competition with Substrate Binding--
A
high concentration of metal ions interferes with enzyme activity. To
test whether decreased activity is due to competition between the metal
ions and positively charged amino acid residues with DNA substrate, we
assayed the Mg2+ dependence of the five mutants indicated
previously. Our results show that the mutants have slightly lower
maximal activities at optimal Mg2+ concentration for both
flap endonuclease and exonuclease activities (Fig.
7 and data not shown). Moreover the metal
concentration ranges for the activities have significantly reduced
toward the lower [Mg2+] end in R47A and R70A mutants and
in their derivatives compared with the wild type enzyme. However, R73A
had a profile very similar to the wild type enzyme. This result may
indicate that mutations of substrate binding residues Arg-47 and Arg-70
lead to decreased tolerance of Mg2+ competition with
substrate binding.
|
| |
DISCUSSION |
|---|
|
|
|---|
To explain the structure-specific nature of FEN-1, Bambara and his colleagues (41, 42) have proposed a thread-through model based on their elegant biochemical data from mammalian enzymes. They hypothesized that there exists a hole in the FEN-1 protein that is large enough for single-stranded DNA to thread through but not for double-stranded DNA. Circumstantial evidence supporting this hypothesis has emerged. The structure of a viral homologue of FEN-1, T5 exonuclease, has revealed an arch structure formed by an N-terminal helix and a helical region located between the two conserved nuclease motifs. Several positively charged and bulky amino acid residues exist on the inner side of this archway, which may be involved in interactions with single-stranded DNA substrate (31). Recently Xu et al. (43) experimentally tested the DNA binding role of the corresponding residues in the 5' nuclease of E. coli DNA polymerase I. They found that two highly conserved basic residues, Lys-78 and Arg-81, reside close to the phosphodiester bond immediately 5' to the cleavage site, while the third highly conserved residue, Arg-20, may interact with the phosphodiester 3' to the cleavage site. Another lysine residue (Lys-83) has been identified in T5 5'-3' exonuclease as a determinant for cleavage sites in the flap DNA substrate (44). Unfortunately these residues are not conserved in eukaryotic homologues. Therefore, information revealed from experimentation with the prokaryotic homologues may not be directly applicable to the eukaryotic enzymes. The crystal structures of two archae FEN-1 proteins have indicated the presence of an unusual helical arch motif, which forms a hole in the FEN-1 protein (32, 33). It has been proposed that the active site groove, the arch region, and the metal ion environments constrain possible duplex and flap strand substrate positions and support induced conformational changes of FEN-1 proteins upon DNA binding and catalysis (32).
In addition, two structural motifs possibly mediate binding of the double-stranded and single-stranded regions of the flap DNA substrate. They include the H3TH motif, which forms a platform that links nonspecific double-stranded DNA to the active site, and the helical clamp motif, which enables passage of the 5' flap strand and caps the active site to facilitate phosphodiester bond cleavage (32). While the importance of these structural elements needs to be tested, we found that two arginine residues from other structural elements are also critical for binding the DNA substrates in this report.
Arginine residues 47 and 70 appear to be involved in substrate binding as demonstrated by a variety of experiments in this report. The nuclease assays indicated that the R70A mutation more severely impairs flap endo- and exonuclease activities as compared with R47A. Direct binding assays and kinetic analysis further verified this observation. Arg-47 is a major determinant of the cleavage sites. However, when the R47A or R70A mutation was combined with the D181A mutation and the double mutants were used to carry out the suppression assay with the wild type enzyme, the R47A/D181A mutant was not able to suppress wild type enzyme activity as efficiently (Fig. 3). This result indicates that R47A/D181A has more severely impaired binding ability to both flap and nicked double-stranded DNA substrates, while its conformation is largely unchanged as verified by CD spectra. The impaired binding is probably due to a synergistic effect of the R47A and D181A mutations on the single protein.
It is reasonable to hypothesize that there exist various structural elements of the FEN-1 molecule that interact with different portions of the flap DNA substrate. The enzymatic activities respond to heterogenous substrate configurations ranging from the double flap (Fig. 5B), 5' single flap, pseudo Y (missing the upstream primer), 5' overhang (Fig. 5A), and nicked double-stranded duplex (Fig. 2B) to a simple duplex configuration (34). The results might indicate that Arg-70 of human FEN-1 protein is mainly involved in the interaction with upstream primer. We have quantitatively compared product intensities of the wild type and R70A enzymes with normal flap and pseudo Y substrates and found that the overall enzyme activity reduction between wild type and R70A proteins is similar. There is no further activity reduction due to additional loss of the upstream substrate configurations (the loss of primer). Mutation of Arg-47 leads to reduction of cleavage efficiency at the Pos19 site. This is probably due to the interaction between Arg-47 and the upstream template strand. Loss of the upstream primer did not affect the cleavage efficiency at Pos19 of the R47A, while loss of the whole upstream duplex completely abolished production of the 19-nt product with all three FEN-1 proteins (Fig. 5A). This is consistent with our other observation that protonation of Arg-47, mimicking the alanine substitution for Arg-47, also shifted the cleavage sites from Pos19 and Pos21 to the single site of Pos21 based on flap substrate and from Pos1, Pos2, and Pos3 to Pos2 and Pos3 based on exonuclease substrate. A shortened single-stranded flap (6 nucleotides, Fig. 5B) also resulted in a single cleavage site, possibly due to restriction of enzyme movement on the flap substrate.
Although these results allowed us to believe that Arg-47 and Arg-70 could be involved in the interaction with upstream duplex of the normal flap substrate, it did not exclude a possibility that the residues also interact with the single-stranded flap strand. As revealed previously, the mutation of Arg-70 or Arg-47 into alanine has a significant effect on the exonuclease activity of FEN-1 with a substrate missing the flap strand. Particularly the R70A mutation led to the loss of exonuclease activity (Fig. 2 and Table III). This result indicates that Arg-47 and Arg-70 are not involved in the interaction with the flap strand.
The FEN-1 enzyme activity requires divalent metal ions such as Mg2+ and Mn2+. These metals are critical for the stimulation of FEN-1 protein by stabilizing protein structure and participating in the catalysis reaction. On the other hand, higher concentrations of the metal may affect DNA-protein interaction or complex stability. Certainly this hypothesis requires further investigation. Nevertheless it may explain why nucleases have an optimal metal concentration for their activities beyond which enzyme activity is inhibited. For the enzyme activity of wild type hFEN-1, the optimal Mg2+ concentration was shown to be around 5 mM. If a high concentration of Mg2+ disrupts protein-DNA interactions as we hypothesized, we would expect that neutralization of the positively charged amino acid residues involved in protein-DNA interaction could shift the optimal Mg2+ concentration to a lower position. To test this hypothesis, we assayed the Mg2+ dependence of the five mutants. Our results show that the Mg2+ concentration range for the nuclease activities shifted to the lower side for all the mutants except for R73A (Fig. 7), indicating that mutations of Arg-47 and Arg-70 decrease the tolerance of the enzyme to Mg2+ competition with substrate binding.
In summary, this report represents an attempt to identify eukaryotic
FEN-1 residues involved in substrate binding. The interactions of the
residues Arg-47 and Arg-70 have mainly or partly been mapped to the
upstream double-stranded portion of a flap or a nicked duplex DNA
substrate. Protonation of the residues and high concentrations of metal
ions interfere with such key protein-substrate interactions. Further
work will be needed to achieve a more comprehensive understanding of
the structural and functional relationship of this unique family of
structure-specific nucleases, particularly a more complete definition
of key structural elements for substrate binding.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Li Zheng and other members of the Shen laboratory for technical assistance and stimulating discussions during the course of this study and Tim O'Connor for critical comments on the manuscript. We are grateful for the opportunity to collaborate with the J. A. Tainer laboratory at the Scripps Research Institute in solving the crystal structure of P. furiosus FEN-1 nuclease, which was used as a template for molecular modeling in this study.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grants CA73764 and CA81967 (to B. H. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: Broward Surgical Associates, Ft. Lauderdale, FL 33308.
§ Present address: Washington University School of Medicine, St. Louis, MO 63110.
¶ To whom correspondences should be addressed: Division of Molecular Medicine, City of Hope National Medical Center and Beckman Research Inst., 1500 East Duarte Rd., Duarte, CA 91010. Tel.: 626-301-8879; Fax: 626-301-8972; E-mail: bshen@coh.org.
Published, JBC Papers in Press, May 1, 2002, DOI 10.1074/jbc.M111941200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: FEN-1, flap endonuclease-1; PCNA, proliferating cell nuclear antigen; hFEN-1, human FEN-1; Pos, position; nt, nucleotide(s).
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Waga, S., and Stillman, B. (1994) Nature 369, 207-212[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Waga, S.,
Bauer, G.,
and Stillman, B.
(1994)
J. Biol. Chem.
269,
10923-10934 |
| 3. | Harrington, J. J., and Lieber, M. R. (1994a) EMBO J. 13, 1235-1246[Medline] [Order article via Infotrieve] |
| 4. |
Harrington, J. J.,
and Lieber, M. R.
(1994b)
Genes Dev.
8,
1344-1355 |
| 5. | Turchi, J. J., Huang, L., Murante, R. S., Kim, Y., and Bambara, R. A. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 8903-9807 |
| 6. |
Murray, J. M.,
Tavassoli, M.,
al Harithy, R.,
Sheldrick, K. S.,
Lehmann, A. R.,
Carr, A. M.,
and Watts, F. Z.
(1994)
Mol. Cell. Biol.
14,
4878-4888 |
| 7. |
Reagan, M. S.,
Pittenberger, C.,
Siede, W.,
and Friedberg, E. C.
(1995)
J. Bacteriol.
177,
364-371 |
| 8. |
Sommers, C. H.,
Miller, E. J.,
Dujon, B.,
Prakash, S.,
and Prakash, L.
(1995)
J. Biol. Chem.
270,
4193-4196 |
| 9. |
Johnson, R. E.,
Kovvali, G. K.,
Prakash, L.,
and Prakash, S.
(1995)
Science
269,
238-240 |
| 10. | Tishkoff, D. X., Filosi, N., Gaida, G. M., and Kolodner, R. D. (1997) Cell 88, 263-263 |
| 11. | Yoon, J.-H., Swiderski, P., Kaplan, B. E., Takao, M., Yasui, A., Shen, B., and Pfeifer, G. P. (1999) Biochemistry 39, 4909-4917 |
| 12. | Brosh, R. M., Jr., Kobbe, C., Sommers, J. A., Karmaker, P., Opresko, P. L., Piotrowski, J., Dianova, I., Dianov, G., L., and Bohr, V. A. (2001) EMBO J. 20, 5791-5801[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Li, X., Li, J.,
Harrington, J. J.,
Lieber, M. R.,
and Burgers, P. M. J.
(1995)
J. Biol. Chem.
270,
22109-22112 |
| 14. |
Wu, X., Li, J., Li, X.,
Hsieh, C.-L.,
Burgers, P. M. J.,
and Lieber, M. R.
(1996)
Nucleic Acids Res.
24,
2036-2043 |
| 15. |
Qiu, J., Li, X.,
Frank, G.,
and Shen, B.
(2001)
J. Biol. Chem.
276,
4901-4908 |
| 16. | Gordenin, D. A., Kunkel, T. A., and Resnick, M. A. (1997) Nat. Genet. 16, 116-118[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Freudenreich, C. H.,
Kantrow, S. M.,
and Zakian, V. A.
(1998)
Science
279,
853-856 |
| 18. | Spiro, C., Pelletier, R., Rolfsmeier, M. L., Dixon, M. J., Lahue, R. S., Gupta, G., Park, M. S., Chen, X., Mariappan, S. V. S., and McMurray, C. T. (1999) Mol. Cell 4, 1079-1085[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Tom, S.,
Henricksen, L. A.,
and Bambara, R. A.
(2000)
J. Biol. Chem.
275,
10498-10505 |
| 20. |
Negritto, M. C.,
Qiu, J.,
Ratay, D. O.,
Shen, B.,
and Bailis, A. M.
(2001)
Mol. Cell. Biol.
21,
2349-2358 |
| 21. | Kunkel, T. A., Resnick, M. A., and Gordenin, D. A. (1997) Cell 88, 155-158[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Ma, X., Jin, Q., Forsti, A., Hemminki, K., and Kumar, R. (2000) Int. J. Cancer 88, 938-942[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Shen, B., Qiu, J., Hosfield, D., and Tainer, J. A. (1998) TIBS 23, 171-173[Medline] [Order article via Infotrieve] |
| 24. | Warbrick, E., Lane, D. P., Glover, D. M., and Cox, L. S. (1997) Oncogene 14, 2313-2321[CrossRef][Medline] [Order article via Infotrieve] |
| 25. |
Frank, G.,
Qiu, J.,
Zheng, L.,
and Shen, B.
(2001)
J. Biol. Chem.
276,
36295-36302 |
| 26. | Klungland, A., and Lindahl, T. (1997) EMBO J. 16, 3341-3348[CrossRef][Medline] [Order article via Infotrieve] |
| 27. |
Kim, K.,
Biade, S.,
and Matsumoto, Y.
(1998)
J. Biol. Chem.
273,
8842-8848 |
| 28. |
Shibata, Y.,
and Nakamura, T.
(2002)
J. Biol. Chem.
277,
746-754 |
| 29. | Kim, Y., Eom, S. H., Wang, J., Lee, D. S., Suh, S. W., and Steitz, T. A. (1995) Nature 376, 612-616[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Mueser, T. C., Nossal, N. G., and Hyde, C. C. (1996) Cell 85, 1101-1112[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Ceska, T. A., Sayers, J. R., Stier, G., and Suck, D. (1996) Nature 382, 90-93[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Hosfield, D., Mol, C. D., Shen, B., and Tainer, J. A. (1998) Cell 95, 135-146[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Hwang, K. Y., Baek, K., Kim, H.-Y., and Cho, Y. (1998) Nat. Struct. Biol. 5, 707-713[CrossRef][Medline] [Order article via Infotrieve] |
| 34. |
Frank, G.,
Qiu, J.,
Somsouk, M.,
Weng, Y.,
Somsouk, L.,
Nolan, J.,
and Shen, B.
(1998)
J. Biol. Chem.
273,
33064-33072 |
| 35. |
Hosfield, D. J.,
Frank, G.,
Weng, Y.,
Tainer, J. A.,
and Shen, B.
(1998)
J. Biol. Chem.
273,
27154-27161 |
| 36. |
Qiu, J.,
Qian, Y.,
Frank, P.,
Wintersberger, U.,
and Shen, B.
(1999)
Mol. Cell. Biol.
19,
8361-8371 |
| 37. | Nolan, J. P., Shen, B., Park, M. S., and Sklar, L. A. (1996) Biochemistry 35, 11668-11676[CrossRef][Medline] [Order article via Infotrieve] |
| 38. |
Shen, B.,
Nolan, J. P.,
Sklar, L. A.,
and Park, M. S.
(1996)
J. Biol. Chem.
271,
9173-9176 |
| 39. | Gomes, X. V., and Burgers, P. M. (2000) EMBO J. 19, 3811-3821[CrossRef][Medline] [Order article via Infotrieve] |
| 40. |
Lyamichev, V.,
Brow, M. A. D.,
Varvel, V. E.,
and Dahlberg, J. E.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
6143-6148 |
| 41. |
Murante, R.,
Rust, L.,
and Bambara, R. A.
(1995)
J. Biol. Chem.
270,
30377-30383 |
| 42. |
Bambara, R. A.,
Murante, R. S.,
and Henricksen, L. A.
(1997)
J. Biol. Chem.
272,
4647-4650 |
| 43. |
Xu, Y.,
Potapova, O.,
Leschziner, A. E.,
Grindley, N. D. F.,
and Joyce, C. M.
(2001)
J. Biol. Chem.
276,
30167-30177 |
| 44. |
Garforth, S. J.,
Ceska, T. A.,
Suck, D.,
and Jayers, J. R.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
38-43 |
This article has been cited by other articles:
![]() |
J. Qiu, J.-H. Yoon, and B. Shen Search for Apoptotic Nucleases in Yeast: ROLE OF Tat-D NUCLEASE IN APOPTOTIC DNA DEGRADATION J. Biol. Chem., April 15, 2005; 280(15): 15370 - 15379. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Qiu, R. Liu, B. R. Chapados, M. Sherman, J. A. Tainer, and B. Shen Interaction Interface of Human Flap Endonuclease-1 with Its DNA Substrates J. Biol. Chem., June 4, 2004; 279(23): 24394 - 24402. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Matsui, J. Abe, H. Yokoyama, and I. Matsui Aromatic Residues Located Close to the Active Center Are Essential for the Catalytic Reaction of Flap Endonuclease-1 from Hyperthermophilic Archaeon Pyrococcus horikoshii J. Biol. Chem., April 16, 2004; 279(16): 16687 - 16696. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||